Ignite Creation Date:
2025-12-24 @ 3:50 PM
Ignite Modification Date:
2026-01-10 @ 4:56 AM
Study NCT ID:
NCT03059992
Status:
COMPLETED
Last Update Posted:
2024-11-20
First Post:
2017-02-14
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study to Evaluate the Efficacy and Safety of Ibrexafungerp in Patients With Fungal Diseases That Are Refractory to or Intolerant of Standard Antifungal Treatment
Sponsor:
Scynexis, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-04-01
Start Date Type:
ACTUAL
Primary Completion Date:
2023-08-25
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-08-25
Completion Date Type:
ACTUAL
First Submit Date:
2017-02-14
First Submit QC Date:
None
Study First Post Date:
2017-02-23
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-09-19
Results First Submit QC Date:
None
Results First Post Date:
2024-11-20
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-28
Last Update Post Date:
2024-11-20
Last Update Post Date Type:
ACTUAL